Quantum-Si Gains 21, Insider Trades Reap Benefit
QSI Stock | USD 1.14 0.09 7.32% |
Under 57% of QuantumSi's investor base is looking to short. The analysis of the overall investor sentiment regarding QuantumSi suggests that many traders are alarmed. QuantumSi's investing sentiment shows overall attitude of investors towards QuantumSi.
QuantumSi |
Insiders who bought Quantum-Si incorporated stock in the last 12 months were richly rewarded last week...
Read at finance.yahoo.com
QuantumSi Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards QuantumSi can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
QuantumSi Fundamental Analysis
We analyze QuantumSi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of QuantumSi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of QuantumSi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
QuantumSi is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
QuantumSi Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with QuantumSi stock to make a market-neutral strategy. Peer analysis of QuantumSi could also be used in its relative valuation, which is a method of valuing QuantumSi by comparing valuation metrics with similar companies.
Peers
QuantumSi Related Equities
CRBU | Caribou Biosciences | 8.91 | ||||
VERV | Verve Therapeutics | 8.85 | ||||
HOOK | Hookipa Pharma | 6.90 | ||||
HRTX | Heron Therapeuti | 5.45 | ||||
BEAM | Beam Therapeutics | 5.26 | ||||
BDTX | Black Diamond | 4.05 | ||||
NTLA | Intellia Therapeutics | 3.26 | ||||
CRSP | Crispr Therapeutics | 3.10 | ||||
ABOS | Acumen Pharmaceuticals | 2.73 | ||||
SEER | Seer | 0.81 | ||||
EDIT | Editas Medicine | 0.45 | ||||
ALEC | Alector | 0.78 | ||||
RNA | Avidity Biosciences | 1.07 | ||||
PRME | Prime Medicine, | 1.20 | ||||
NRIX | Nurix Therapeutics | 2.57 | ||||
MNOV | MediciNova | 3.37 | ||||
HCWB | HCW Biologics | 10.34 | ||||
PASG | Passage Bio | 11.12 |
Complementary Tools for QuantumSi Stock analysis
When running QuantumSi's price analysis, check to measure QuantumSi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuantumSi is operating at the current time. Most of QuantumSi's value examination focuses on studying past and present price action to predict the probability of QuantumSi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuantumSi's price. Additionally, you may evaluate how the addition of QuantumSi to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |